Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Oct 15, 2021 8:51pm
154 Views
Post# 34012647

Today’s House Positions

Today’s House Positions
House Positions for C:ARCH from 20211015 to 20211015
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 51,800 129,116 2.493 4,000 10,600 2.65 47,800 -118,516
83 Mackie 28,300 74,967 2.649 0   28,300 -74,967
7 TD Sec 45,263 113,332 2.504 39,803 101,715 2.555 5,460 -11,617
28 BBS 400 1,032 2.58 0   400 -1,032
84 Ind Trading 66 155 2.348 0   66 -155
19 Desjardins 50 131 2.62 0   50 -131
68 Leede 543 1,352 2.49 503 1,301 2.586 40 -51
14 ITG 0   96 239 2.49 -96 239
53 Morgan Stanley 14 35 2.50 293 703 2.399 -279 668
33 Canaccord 4,000 9,690 2.423 5,000 12,298 2.46 -1,000 2,608
13 Instinet 5,200 12,753 2.453 7,400 18,445 2.493 -2,200 5,692
80 National Bank 3,249 8,254 2.54 6,100 15,525 2.545 -2,851 7,271
9 BMO Nesbitt 3,000 7,798 2.599 6,500 17,065 2.625 -3,500 9,267
124 Questrade 365 916 2.51 4,366 10,270 2.352 -4,001 9,354
85 Scotia 3,518 9,179 2.609 8,550 21,967 2.569 -5,032 12,788
2 RBC 3,780 9,518 2.518 14,085 34,866 2.475 -10,305 25,348
79 CIBC 18,900 47,617 2.519 34,902 87,446 2.505 -16,002 39,829
1 Anonymous 60,350 149,205 2.472 97,200 242,611 2.496 -36,850 93,406
TOTAL 228,798 575,050 2.513 228,798 575,051 2.513 0 1

<< Previous
Bullboard Posts
Next >>